From April 1, 2024 to June 30, 2024, the company has repurchased 6,592,605 shares, representing 0.47% for CNY 187.73 million. With this, the company has completed the repurchase of 8,080,805 shares, representing 0.58% for CNY 226.96 million under the buyback announced on September 21, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
24.64 CNY | +7.18% |
|
-2.34% | -19.26% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-19.26% | 4.76B | |
+13.33% | 8.13B | |
+6.62% | 7.91B | |
-8.54% | 3.63B | |
-20.61% | 3.16B | |
-12.55% | 1.2B | |
-26.47% | 1.12B | |
-7.63% | 892M | |
-17.95% | 838M | |
-11.48% | 761M |
- Stock Market
- Equities
- 300765 Stock
- News CSPC Innovation Pharmaceutical Co., Ltd.
- Tranche Update on CSPC Innovation Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on September 21, 2023.